MolecularMD has earned its reputation in industry-leading Quantitative Reverse Transcription Polymerase Chain Reaction (Q-RT-PCR) BCR/ABL testing services. Our Q-RT-PCR BCR/ABL testing service for patients receiving ABL kinase inhibitors for Ph+ Chronic Myelogenous Leukemia provides superlative sensitivity and reproducibility at low residual disease levels. It also employs international standardization methods required for reporting Major Molecular Response (MMR). MMR is an important treatment milestone linked to completeness and durability of patient response.
BCR/ABL testing methods across various labs vary in sensitivity performance, reagent quality, and control methods. Therefore, standardization is the only way to directly compare performance among laboratories and relative clinical response among patients. MolecularMD is consistently rated as the highest performing lab among international standardized laboratories. This is due primarily to our exceptional quality control standards and analytical performance of our PCR and control reagents.
To begin incorporating the best Q-RT-PCR BCR/ABL testing services in your oncology practice, call 1-877-459-4979 to request a specimen collection kit.